H.R. 1266 · 119th Congress — Combating Illicit Xylazine Act
Combating Illicit Xylazine Act This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug…
- Congress
- 119
- Bill
- HR 1266
- Status
- Latest Action
- Introduced
- 2025-02-12
- Latest action date
- 2026-09-15
Record overview
Combating Illicit Xylazine Act This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine. This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA.
Topics covered in the available bill text
- Section 3: Adding xylazine to schedule iii
- Section 4: Amendments
- Section 5: Arcos tracking
- Section 6: Sentencing commission
- Section 7: Report to congress on xylazine
Selected section headings from the available bill text; this outline does not cover every provision or amendment.
Latest action
Motion to reconsider laid on the table Agreed to without objection.
Sponsors
- Rep. Panetta, Jimmy [D-CA-19]
California · House District 19 · Democratic
Record provenance
Stored record updated: 2026-09-16. This is separate from the action date and does not establish enactment.